2023 Biosimilars Process Improvement 
European Pharmaceutical Review
FEBRUARY 20, 2024
Based on the report’s data, the market is also advancing due to greater amount of research being conducted on the production of biosimilars/biomolecules, monoclonal antibodies, and tiny therapeutic peptides.
Express Pharma
JULY 10, 2024
With advancements in biotechnology, robust scientific capabilities, cost-effective manufacturing processes, a large workforce and a shift towards more complex biologic drugs, India is at the cusp of a huge opportunity to emerge as a leader in biopharma. Only then can tomorrow’s giant businesses emerge from today’s unicorns.”
Expert insights. Personalized for you.
98 
Let's personalize your content